IDN
Earnings company data as of 4:48 AM ET 10/23
- 0 of 1 EPS beats
History
2 periods, newest first. Each row shows EPS above revenue.
| Period | Date | Metric | Estimate | Actual | Result |
|---|---|---|---|---|---|
| FY2026 Q3 | 11 Nov | EPS | 0.01 | — | — |
| Rev | — | — | — | ||
| FY2026 Q2 | 13 Aug | EPS | 0.03 | 0.03 | In line |
| Rev | — | $5.9M | — |
Insider trades
Open-market buys and sales by IDN's executives, directors and 10% owners in the last 12 months, from their Form 4s
- $6,180 bought by 1 insider
- $23K sold by 1 insider outside a trading plan
- $320K sold by 1 insider under 10b5-1 plans
-
Jonathan Robins Chief Technology OfficerSale$23K 5,550 shares at $4.22 100% of stakeTraded Jun 15 Filed Jun 16
-
Bryan Lewis CEOPlanned sale$81K 10,000 shares at $8.05 20% of stakeTraded Apr 27 Filed Apr 28
-
Bryan Lewis CEOPlanned sale$85K 10,000 shares at $8.51 17% of stakeTraded Apr 20 Filed Apr 21
-
Bryan Lewis CEOPlanned sale$80K 10,000 shares at $7.95 14% of stakeTraded Apr 13 Filed Apr 14
-
Bryan Lewis CEOPlanned sale$75K 10,000 shares at $7.53 13% of stakeTraded Apr 6 Filed Apr 7
-
Guy L Smith DirectorBuy$6,180 1,000 shares at $6.18 +0.3% to stakeTraded Nov 25, 2025 Filed Nov 25, 2025
Also filed in the last 12 months, not counted as buying or selling: 12 stock grants and 2 gifts.
SEC filings
Recent issuer filings from EDGAR, 18 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 5.03,9.01 | Filing Doc | |
| 8-K | 5.02 | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc | |
| DEF 14A | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-K | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G | — | Filing Doc |
No filings match this filter.
Estimates are consensus figures; SEC filings remain the official record. Not investment advice.